Nombre del producto:1-(2-methanesulfonyl-1,2,3,4-tetrahydroisoquinolin-5-yl)-5-methyl-1H-1,2,3-triazole-4-carboxylic acid

IUPAC Name:1-(2-methanesulfonyl-1,2,3,4-tetrahydroisoquinolin-5-yl)-5-methyl-1H-1,2,3-triazole-4-carboxylic acid

CAS:1306604-91-0
Fórmula molecular:C14H16N4O4S
Pureza:95%+
Número de catálogo:CM476584
Peso molecular:336.37

Unidad de embalaje Stock disponible Precio($) Cantidad
CM476584-250mg 3-4 Weeks ƞȀň
CM476584-500mg 4-5 Weeks Ŕƞƞ
CM476584-1g 4-5 Weeks ňƞǕ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :1306604-91-0
Fórmula molecular:C14H16N4O4S
Punto de fusión:-
Código de sonrisas:CC1=C(N=NN1C1=CC=CC2=C1CCN(C2)S(C)(=O)=O)C(O)=O
Densidad:
Número de catálogo:CM476584
Peso molecular:336.37
Punto de ebullición:
Nº Mdl:MFCD18838671
Almacenamiento:

Category Infos

Triazoles
Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.
Tetrahydroisoquinolines
Tetrahydroisoquinoline is an organic compound with the chemical formula C9H11N. It is classified as a secondary amine, obtained from isoquinoline by hydrogenation. The tetrahydroisoquinoline moiety forms the backbone of several natural, synthetic and semi-synthetic drugs approved for the treatment of cancer, pain, gout and various neurodegenerative diseases.

Related Products